EDITOR,-We read with interest the study that compared intraoperative mitomycin C with irradiation in primary pterygium surgery. 1 The authors rightly commented that long term complications of irradiation, such as scleral necrosis, may arise more than 10 years after the irradiation.
2 Moriarty AP, Crawford GJ, McAllister IL, et al. Severe corneoscleral infection. A complication of beta irradiation scleral necrosis following pterygium excision. Arch Ophthalmol 1993;111: 947-51.
Visual field defects after vitrectomy with fluid-air exchange
EDITOR,-The paper by Cullinane and Cleary 1 presents an excellent prospective study of peripheral visual field loss in patients undergoing macular hole surgery. The authors compared vitrectomy with complete posterior cortical vitreous peeling to limited vitrectomy with removal of cortical vitreous oV the macula, but not oV the optic nerve head or the peripheral retina. The authors showed a statistically significant decrease in peripheral visual field defects with the limited vitrectomy technique (0%, 0/22 patients) compared with the complete vitrectomy group (22%, 18/82 patients).
The authors postulated that this diVerence is due to the avoidance of traction on the optic nerve head during peeling of the posterior hyaloid, thus limiting damage to the peripapillary nerve fibre layer, which they believed would be most severe nasally because of firmer vitreopapillary attachments nasally. This explanation does not take into account the variable position of visual field defects found in other studies based on the position of the infusion cannula. If the infusion cannula is superiorly located, visual field defects occur superiorly, implicating inferior retinal damage.
2 If the infusion cannula is inferonasal, visual field defects occur inferonasally and not inferotemporally. 3 The inferotemporal location of field defects noted in most studies is based on the conventional placement of the infusion cannula inferotemporally in three port vitrectomy, which results in infused air directed towards the superonasal midperipheral retina.
Animal studies show damage to the inner limiting membrane, nerve fibre layer, and ganglion cells of the retina in the path of the pressurised air flow from the infusion cannula. 4 5 This inner retinal damage could be caused by desiccation of the retina 2 or by direct mechanical damage by the pressurised air flow.
4 5 However, humidification of air did not prevent inner retinal damage in animal models, 4 5 and the sharp demarcation between damaged and undamaged retina on electron microscopic studies supports the theory of direct mechanical damage to the inner retina. 4 In addition, decreasing the infusion air pressure also decreased the risk of inner retinal damage.
5 What I think this work by Cullinane and Gleary shows is that leaving the peripheral vitreous in place is another way of protecting the peripheral retina from mechanical damage by pressurised air flow. However, I would be concerned about the potential risk of increased postoperative retinal detachment, which was 10% in the limited vitrectomy group and 4% in the complete vitrectomy group, but was not statistically significant because of small sample size. However, this increased risk of retinal detachment was also a concern in a previous study utilising similar surgical techniques (Brian Conway, Western Association for Vitreoretinal Education Meeting, Maui, Hawaii, 1996) .
Because of the studies on retinal damage by pressurised air infusion and the significance of high infusion air pressure, it would be important to know the usual infusion air pressure utilised during fluid-air exchange by the authors, and if the infusion air pressure varied at any point during the period of the study or between the two vitrectomy groups. Currently, in order to minimise retinal damage induced by pressurised air infusion during vitrectomy for any surgical indication requiring fluid-air exchange, I would recommend simply using a low infusion air pressure. Part of the controversy is due to a misunderstanding of the nature and pathogenesis of FVI. As McLeod points out in his editorial, FVI is a term that has been used inadvisedly, suggesting that episcleral tissue grows into the eye through the sclerotomy incision.
2 While episcleral tissue, scleral fibroblasts, and ciliary epithelium all contribute, the majority of the fibroproliferative healing of a sclerotomy originates from the uvea of the ciliary body.
McLeod pointed out that ischaemia is an important factor in inducing FVI and that it is seen mainly following vitrectomy for ischaemic retinopathies. I agree that this is the case if one includes anterior proliferative vitreoretinopathy (APVR) in this group. Patients with APVR who have had previous vitrectomy frequently have an excessive amount of fibrovascular scarring from their sclerotomies, which significantly aVects the pathological anatomy of the basal vitreous and its environs. These patients, however, often have had extensive scleral buckling and cryopexy, processes which undoubtedly induce some anterior ischaemia in themselves.
3
In the series of West and Gregor, no patient was found to have a retinal detachment ultrasonographically or at the time of VCWO. In the original description of AHFP, most of the patients had retinal detachments that had required scleral buckling.
5 Since retinal detachment and scleral buckling exacerbate anterior ischaemia, it is likely that AHFP, which is fibrovascular proliferation into the vitreous base from the retina and ciliary body, is induced by an ischaemic drive similar to that causing FVI. The two entities exist on a continuum. When there is a surgical injury such as a sclerotomy, with disruption of tissue and inoculation of blood into the surrounding vitreous, excessive proliferation may occur with less induction than that which causes AHFP.
Personally, although I have observed cases of AHFP without having previous vitrectomy, I have never seen a case of post-vitrectomy AHFP without some concurrent FVI.
Finally, I'd like to make two other points. The first is that West and Gregor used clinical criteria to determine whether or not FVI existed and caused the recurrent vitreous haemorrhage. I have observed vitreous haemorrhage in a necropsy eye from what grossly appeared to be a normally healed sclerotomy wound. 6 Microscopically, that white scar contained numerous capillaries that were the source of the haemorrhage. Therefore, it may be that some of their non-FVI patients might actually have had vitreous haemorrhage from a subclinical FVI. Furthermore, FVI can involute with time, becoming less vascular in its appearance. So, the frequency of FVI may be even higher than reported.
Lastly, I agree that episcleral sentinel vessels, externally entering the wound site, sometimes, but not always, indicate a possible FVI. These vessels are the result of a high degree of metabolic activity during the healing of sclerotomy wounds and may persist even though wound fibroplasia becomes involutional and clinically unimportant. Similar vessels are seen microscopically in the ciliary body.
3 When present, sentinel 3 vessels should raise our suspicions of FVI; but they do not rule it in, nor does their absence rule it out. Corneal transplantation: how successful are we?
EDITOR,-The commentary by Waldock and Cook 1 on the survival rates of corneal grafts highlights a number of issues. In particular, they focus on the lack of long term follow up data in the UK. The value of such data is clearly evident from the Australian Corneal Graft Register.
2 Moreover, in the present climate of clinical audit and evidence based medicine, the collection of such data has surely become a necessity.
3 Many of the questions raised, whether simply comparing graft survival rates of individual units with national data or investigating more fundamental issues such as HLA matching, visual outcome, or surgeon experience require large amounts of data, properly designed studies, and appropriate statistical analysis-capabilities beyond most individual centres but readily achievable within the NHS. The way forward as shown by the organ transplant community, and to a certain extent by corneal graft surgeons, is through well organised, centralised data collection and analysis, for example.
4 5
The good news is that just such a system is now in place for all corneal graft surgeons in the UK. The Royal College of Ophthalmologists and UK Transplant (UKT) have initiated an Ocular Tissue Transplant Audit, which will provide the data for answering the sorts of questions posed by Waldock and Cook.
1 Indeed, the audit is already being used for data capture for the Corneal Transplant Follow-up Study II, which aims to resolve the uncertainty surrounding HLA-DR matching and corneal graft rejection. Instead of just 1 year follow up as in the original CTFS, 5 follow up for these patients will continue in the long term through the audit.
As important, however, is the opportunity for all ocular tissue transplants to be recorded and the outcome audited. Indeed one can foresee the day when this will be obligatory, as is the case with solid organs. To record such data with UKT will not only provide surgeons with details of their own activity, but with an independent confidential analysis of clinical outcomes, which they will increasingly be expected to have available. If only one had time in clinic to become fully dark adapted, instead of listening and talking to patients, all these illustrated wonders of vitreous architecture would yield to routine examination. As it is, much of what we perceive under unfavourable circumstances is, in fact, inferred although vitreous surgery provides regular opportunities for confirmation of the assumed pathology. This atlas of vitreous biomicroscopy provides a wealth of photographic documentation of vitreous disorders, especially as they aVect transparent gel, and is supplemented by images of scanning laser ophthalmoscopy. Much of the material appears to have been published previously over many years and in a variety of journals, but that aspect of compilation and reproduction is welcome. However, the constantly recurring theme of a detached posterior hyaloid face, whether bounding a gel that has or has not collapsed, eventually tends to pall. The text which accompanies the colour figures is parochial in content and disappointingly dull in places. An alleged 10% incidence of PVD in the fifth decade of life is surely peculiar to the Japanese population, and the customary obfuscation of the pathogenic sequence in advanced diabetic eye disease by the Boston group is reiterated. Stickler's arthro-ophthalmolopathy isn't mentioned (only Wagner's disease under "degenerations") and PVD is said to be unusual in association with giant retinal tears. The description of asteroid hyalosis implies a bag of balls instead of strings of pearls, and the text and photographs of vitreous amyloidosis fail to inspire, omitting to mention precipitation of opacity on the otherwise transparent vitreous microarchitecture and thus revealing, for example, remnants of the tunica vasculosa lentis.
This atlas is more likely to figure on the departmental coVee Presented in two volumes, the first includes the text and runs to 1645 pages, divided into five sections, while the second volume sensibly presents a separate bibliography thereby making the text (marginally) more transportable. The first volume is a comprehensive review of the anatomy and physiology of the pupil with its associated neurology and the diseases which play a part in compromising pupil function.
As a physiologist, Loewenfeld has written a book with a thorough foundation in basic science, with comprehensive discussion covering pupillary function across the animal kingdom, not simply restricting the project to humans.
Having been inscribed over a near 40 year period the text has a strong historical perspective, presenting research work in chronological order over a period during which understanding of pupil function has evolved. In striving to be comprehensive Irene Loewenfeld has included papers which may subsequently have been reinterpreted or simply proved incorrect. She has willingly injected a subjective flavour to the book when giving her own interpretation of earlier work which serves to make the text readable. This is also true for the bibliography where she includes "reference manager" style comments about the value of many references.
By its nature, such a reference tome can be diYcult to "dip into". To assist those who may want rapid access to a subject each section is presented on three levels: a "thumbnail" summary for readers in a hurry; elaboration with historical perspectives for those with more time; plus an additional level with material delving into the background for readers keen to look to the source of understanding.
One section where clinical work may be underrepresented is the chapter on glaucoma.
Here the text focuses on historical record of the pharmacological influence of drugs upon pupil function and their role in therapeutics. Recent clinical work on pupillometry in glaucomatous optic neuropathy aimed towards developing "pupil perimetry" has not been presented.
However, with this one exception, this text represents the definitive work upon the pupil which all ophthalmologists will find valuable, either as an introduction to the field or as the last word on the subject. J P DIAMOND 
